This article was originally published in The Gray Sheet
Executive SummaryGains 510(k) clearance for the Vueport balloon occlusion guiding catheter with distal tip compliant balloon for access and enhanced visualization of the coronary venous system for VT mapping. Designed to temporarily occlude the coronary sinus, the catheter allows the physician to inject radiopaque dye to show the vasculature of the heart during fluoroscopy and produce a venogram, Cardima says
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.